Stanley Chetcuti

Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial

Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System

72230 | Novel Predictors of New Pacemaker Implantation and Associated Outcomes Among Patients Undergoing TAVR for Aortic Regurgitation in the ALIGN-AR Trial

TCT-220 Real-world Utilization of PASCAL Precision System in non-A2P2 Degenerative Mitral Regurgitation

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study

Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study

Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction

Clinical Impact of Standardized TAVR Technique and Care Pathway

First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System

Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1)

Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients

Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients